Vantage Market Research report examines the Antibody Drug Conjugates (ADCs) market, forecasting trends and dynamics from 2025 ...

Bioconjugation presents an new frontier for pharmaceutical development, providing an option for improved drug efficacy across ...

In connection with the financing, Serina issued 965,250 shares of convertible preferred stock at $5.18 per share, equivalent to the closing price of its common stock on April 7, 2025.

CHENGDU, China I March 25, 2025 I Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company has received a clinical ...

NEO212 is a proprietary conjugation of temozolomide (TMZ)—the current standard-of-care chemotherapy for malignant gliomas—and perillyl alcohol (POH), a naturally occurring compound with anti-cancer ...

AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published its 2024 Annual Results announcement on March 30, 2025, the company recorded revenues of RMB 1,285 million in 2024, an ...

Novel trispecific T cell engager, ZW209, demonstrates potent preclinical efficacy against DLL3-expressing tumors and an encouraging safety profile. New antibody-drug conjugate (AD ...

MSD has received approval from the EC for Capvaxive, a pneumococcal 21-valent conjugate vaccine, to prevent invasive disease ...

How we use your information depends on the product and service that you use and your relationship with us. We may use it to: Verify your identity, personalize the content you receive, or create ...

Basel, Switzerland Friday, April 4, 2025, 10:00 Hrs [IST] ...